His primary areas of study are Herpes simplex virus, Virology, Oncolytic virus, Molecular biology and Immune system. His research in Herpes simplex virus intersects with topics in Oncolytic Virus Therapy, Vector and Pathology. His Virology research includes themes of MHC class I and Mutant.
His Oncolytic virus research integrates issues from Brain tumor, Cancer stem cell and Glioma. His Molecular biology study incorporates themes from Processivity, DNA clamp, DNA polymerase II, Gene and Klenow fragment. He combines subjects such as Melanoma and Chemotherapy with his study of Virus.
Samuel D. Rabkin spends much of his time researching Oncolytic virus, Herpes simplex virus, Virology, Cancer research and Virus. His studies in Oncolytic virus integrate themes in fields like Cancer cell and Glioma. The various areas that Samuel D. Rabkin examines in his Herpes simplex virus study include Cell culture, Viral replication, Vector, Molecular biology and Genetic enhancement.
Samuel D. Rabkin studied Virology and Gene that intersect with Cell. His Cancer research study combines topics from a wide range of disciplines, such as Interleukin 12, Stem cell and In vivo. His work carried out in the field of Cancer brings together such families of science as Chemotherapy, Combination therapy and Pathology.
Samuel D. Rabkin mainly investigates Oncolytic virus, Cancer research, Herpes simplex virus, Cancer cell and Virology. His Oncolytic virus research is multidisciplinary, relying on both Cancer stem cell and Immunotherapy. His study in Cancer research is interdisciplinary in nature, drawing from both Cytotoxic T cell, Interleukin 12 and In vivo.
His work deals with themes such as Cell culture, Viral replication, Chemotherapy, Malignant meningioma and Kinase, which intersect with Herpes simplex virus. His work in the fields of Virology, such as Virus, overlaps with other areas such as Titration. His biological study spans a wide range of topics, including Molecular biology and Cell.
Samuel D. Rabkin focuses on Oncolytic virus, Cancer research, Cancer cell, Immunology and Herpes simplex virus. His Oncolytic virus research integrates issues from Tumor microenvironment, Cancer stem cell and Glioma. His Cancer research study incorporates themes from DNA damage, Gene knockdown, Poly ADP ribose polymerase, Talimogene laherparepvec and Interleukin 12.
The concepts of his Cancer cell study are interwoven with issues in Immune checkpoint and Cancer immunotherapy. His Herpes simplex virus study is concerned with Virus in general. His research in Virology intersects with topics in Cytotoxic T cell and Apoptosis.
Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial.
J M Markert;M D Medlock;S D Rabkin;G Y Gillespie.
Gene Therapy (2000)
Attenuated multi-mutated herpes simplex virus-1 for the treatment of malignant gliomas
Toshihiro Mineta;Samuel D. Rabkin;Takahito Yazaki;William D. Hunter.
Nature Medicine (1995)
Reconstructing and Reprogramming the Tumor-Propagating Potential of Glioblastoma Stem-like Cells
Mario Luca Suva;Mario Luca Suva;Mario Luca Suva;Esther Rheinbay;Esther Rheinbay;Esther Rheinbay;Shawn M. Gillespie;Shawn M. Gillespie;Shawn M. Gillespie;Anoop Premswaroop Patel;Anoop Premswaroop Patel.
Oncolytic herpes simplex virus vector with enhanced MHC class I presentation and tumor cell killing.
Tomoki Todo;Robert L. Martuza;Samuel D. Rabkin;Paul A. Johnson.
Proceedings of the National Academy of Sciences of the United States of America (2001)
Analgesia and hyperalgesia from GABA-mediated modulation of the cerebral cortex.
Luc Jasmin;Samuel D. Rabkin;Alberto Granato;Abdennacer Boudah.
Herpes simplex virus as an in situ cancer vaccine for the induction of specific anti-tumor immunity.
Masahiro Toda;Samuel D. Rabkin;Hidefumi Kojima;Robert L. Martuza.
Human Gene Therapy (1999)
Human Glioblastoma–Derived Cancer Stem Cells: Establishment of Invasive Glioma Models and Treatment with Oncolytic Herpes Simplex Virus Vectors
Hiroaki Wakimoto;Santosh Kesari;Christopher J. Farrell;William T. Curry.
Cancer Research (2009)
Oncolytic herpes simplex virus vectors for cancer virotherapy
Susan Varghese;Samuel D Rabkin.
Cancer Gene Therapy (2002)
Treatment of Malignant Gliomas Using Ganciclovir-hypersensitive, Ribonucleotide Reductase-deficient Herpes Simplex Viral Mutant'
Toshihiro Mineta;Samuel D. Rabkin;Robert L. Martuza.
Cancer Research (1994)
Oncolytic Viruses and Their Application to Cancer Immunotherapy
Chiocca Ea;Rabkin Sd.
Cancer immunology research (2014)
If you think any of the details on this page are incorrect, let us know.